Accelerating Typhoid Conjugate Vaccine Introduction
This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.
Author: Typhoid Vaccine Acceleration Consortium
» Download file (English)
151 KB PDF (Located at path.azureedge.net)
» Download file (French)
372 KB PDF (Located at path.azureedge.net)
Also known as: Accélérer l’introduction des vaccins antityphoïdiques conjugués